Max H. Yusem

Paul Hastings LLP

General

Experience12 yrs

Elite Ratings

DCT

Practice Areas

Biotech (17 cases)

Chemical (2 cases)

Law Firms

Paul Hastings LLP (Current)

maxyusem@paulhastings.com

paulhastings.com

Ratings

Experience

Grade

Trend

DCT

L4

B

PTAB

--

--

--

CAFC

--

--

--

Cases

Case #	Court	Caption	Filed	Represent
1:25-CV-17403	D. NJ	Kyowa Kirin CO., LTD. v. Sun Pharmaceutical Industries LTD.	11/13/25	Patent Owner :Kyowa Kirin Co Ltd	.
2:23-CV-00222	E.D. VA	Curevac Se v. BioNTech Se	05/19/23	Patent Owner :BioNTech Mfg GmbH	.
3:23-CV-01876	D. NJ	Arbutus Pharma Corp v. Pfizer Inc	04/04/23	Challenger :BioNTech Se	.
1:21-CV-01478	D. DE	San Rocco Therap LLC v. Bluebird Bio Inc	10/21/21	Challenger(W) :Bluebird Bio Inc	.
4:20-CV-08624	N.D. CA	AbCellera Biologics Inc v. Bruker Cellular Analysis Inc	12/07/20	Patent Owner :AbCellera Biologics Inc	.
2:20-CV-12470	D. NJ	Alkermes Inc v. Teva Pharmaceutical Industries USA Inc	09/09/20	Patent Owner :Alkermes Pharma Ireland Ltd	.
3:20-CV-03106	D. NJ	Mitsubishi Tanabe Pharma Corp v. Aurobindo Pharma USA Inc	03/20/20	Patent Owner(W) :Cilag GMBH	.
3:17-CV-12082	D. NJ	Mitsubishi Tanabe Pharma Corp v. Aurobindo Pharma USA Inc	11/27/17	Patent Owner(W) :Cilag GMBH	.
3:17-CV-06375	D. NJ	Mitsubishi Tanabe Pharma Corp v. InvaGen Pharma Inc	08/23/17	Patent Owner(W) :Cilag GMBH	.
1:17-CV-01065	D. DE	AbbVie Inc v. Boehringer Ingelheim Intl GmbH	08/02/17	Challenger :Boehringer Ingelheim Intl GmbH	.

Ratings Trends

Practice Areas